COCP — Cocrystal Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Cocrystal Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14.2 | -38.8 | -18 | -17.5 | -8.83 |
| Depreciation | |||||
| Non-Cash Items | 0.672 | 19.9 | 0.787 | 0.753 | 0.574 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.604 | -2.71 | 2.34 | 0.14 | -0.007 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -12.7 | -21.4 | -14.7 | -16.5 | -8.19 |
| Capital Expenditures | -0.052 | -0.074 | -0.118 | -0.008 | -0.012 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.052 | -0.074 | -0.118 | -0.008 | -0.012 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 38.5 | -0.027 | 3.99 | — | 5.37 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 25.7 | -21.5 | -10.8 | -16.5 | -2.83 |